Content

The CiteScore of Journal of Cancer Metastasis and Treatment has Increased to 3.2 in 2022

Published on: 8 Jun 2023 Viewed: 637

On June 8th, Elsevier released the latest CiteScore. We are delighted to report that the 2022 CiteScore of Journal of Cancer Metastasis and Treatment(JCMT) has shown a significant increase. It has grown from 0.4 to 3.2. This substantial rise highlights the impactful and high-quality content published by JCMT in the field of oncology, reaffirming the journal's continuous progress.

CiteScore is a set of metrics that measure a scholarly journal’s impact by analyzing the average number of citations per item it received over a three-year period. It covers over 22,500 journals indexed in Scopus, Elsevier’s comprehensive citation database.

We would like to express our sincere appreciation to all the authors, Editorial Board Members, reviewers, and readers for their invaluable contribution and unwavering support, which collectively contribute to the journal’s achievement.

Here are some highly cited articles worth recommending:

JCMT will continue publishing high-quality papers that advance and lead scientific developments in the field of oncology.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/